Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
Despite Improvement Efforts, the "State of the Air" Report Highlights Issues.
Read Full NewsLack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
Base-edited T-cell therapy offers additional hope for treating resistant leukemia.
3.
Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.
4.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
5.
UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts
1.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
2.
Understanding Fibrosarcoma: What You Need to Know
3.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
4.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
5.
Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge